The focus of our work is the study and investigation of pathogens which are medically relevant or can be used as models for researching infection mechanisms.
To the research topics
Around 700 employees in research, administration and infrastructure, and about 140 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research.
Our scientists pursue research to expand our knowledge of the fundamental mechanisms behind medically relevant infectious diseases.
To the open positions
The Friends of the Helmholtz Centre for Infection Research support dedicated young scientists and promote their networking with other researchers and companies. Furthermore, they enable scientific events and publications.
How pathogens make us sick – and how our immune system fights them
HZI researchers are studying the tricks of bacteria and viruses
The search for better and safer antiinfectives
Bacteria of the Salmonella genus can gain entry to the human body through spoiled or contaminated foods and then cause severe diarrhoeal diseases. But salmonellae can be useful as well: They can colonise tumours to the effect that these can be detected and tackled by the immune system. A serious issue: The salmonella infection can be fatal for cancer patients. Investigating possible therapeutic…
A new class of substances is effective against both the AIDS pathogen, HIV, and antibiotics-resistant MRSA bacteria. These two pathogens often occur together. Scientists hope that it may be possible to control them with a single drug in the future. Scientists of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) developed so-called dual agents that inhibit the growth of…
When bacteria enter the body of a human or animal, they are recognised as foreign matter by the immune system. The immune cells, in turn, try to eliminate these foreign bodies. Scientists of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and their colleagues from the University of Umeå in Sweden recently discovered how Yersinia bacteria manage to kill immune cells at…
Bacteria of the Yersinia genus elicit intestinal wall inflammation and serious diarrhoeal disease as well as other afflictions in humans. This genus includes the plague pathogen. Scientists from the Helmholtz Centre for Infection Research (HZI) and their colleagues from the Ruhr-Universität Bochum and the University of Leipzig recently discovered various molecular switches in Yersinia…
Every year, we see new flu epidemics all over the world, which vary greatly in terms of their magnitude. Once it has entered the body, the influenza virus multiplies in the epithelial cells on the surfaces of the airways. Nevertheless, this does not go unnoticed and the body combats it actively. Alveolar type 2 epithelial cells can be found in the lower airways. For the first time,…
Jürgen Wehland Symposium NoRDI VII
Date: 27.10.2016 | Time: 10:00 a.m.
Location: Helmholtz Centre for Infection Research, Braunschweig
Helmholtz Centre for Infection ResearchInhoffenstraße 738124 Braunschweig+49 531 firstname.lastname@example.org
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)Universitätscampus E8 166123 Saarbrücken+49 681 email@example.com
TWINCOREZentrum für Experimentelle und Klinische InfektionsforschungFeodor-Lynen-Str. 730625 Hannover+49 511 firstname.lastname@example.org
Study Centre HannoverFeodor-Lynen-Straße 1530625 Hannover+49 511 5350 email@example.com